Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.

Scand J Gastroenterol 2006 Feb;41(2):200-4

Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands.

Objective: Decreased bone mineral density (BMD) is common in inflammatory bowel disease (IBD) and an increased risk of fractures has been reported. Guidelines state bisphosphonate treatment for IBD patients with decreased BMD, but orally available bisphosphonates have been associated with gastrointestinal side effects and the absorption is poor. We investigated whether intravenous pamidronate is a safe and effective treatment.

Material And Methods: Forty-nine IBD patients with decreased BMD as assessed by DEXA scan were treated with calcium 1000 mg and vitamin D 400 IU daily. In addition, 30 mg of pamidronate was administered intravenously every 3 months. DEXA scanning was performed prior to treatment, after 6 months and after 1 year.

Results: Of 49 IBD patients, 40 were osteoporotic and 9 were osteopenic. Twenty-six patients were female (mean age 40.8) and 23 were male (mean age 43.3). Treatment was discontinued in one patient because of fever after infusion. Otherwise, tolerability was excellent, and no adverse events were documented. A mean 0.51 increase of lumbar spine (L1-L4) T-scores was observed (CI 95% 0.35-0.67; p<0.0004). The effect of treatment on left femoral neck T-scores was less pronounced: 0.39 (CI 95% 0.24-0.53; p<0.0004).

Conclusions: We conclude that intravenous pamidronate in combination with calcium and vitamin D is a well tolerated strategy for treating Crohn's disease associated osteopenia and osteoporosis. Although uncontrolled, treatment results in a significant increase of BMD in the lumbar spine.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520500206467DOI Listing
February 2006
2 Reads

Publication Analysis

Top Keywords

ibd patients
12
decreased bmd
8
patients decreased
8
inflammatory bowel
8
mineral density
8
intravenous pamidronate
8
bowel disease
8
bone mineral
8
forty-nine ibd
4
methods forty-nine
4
treatmentmaterial methods
4
tolerability excellent
4
dexa scan
4
treated calcium
4
calcium 1000
4
scan treated
4
infusion tolerability
4
assessed dexa
4
bmd assessed
4
safe effective
4

References

(Supplied by CrossRef)

Bernstein CN et al.
Gastroenterology 2003

Card T et al.
Gut 2004

Haderslev KV et al.
Gastroenterology 2000

Robinson RJ et al.
Gastroenterology 1998

Marshall JK et al.
Expert Opin Drug Saf 2002

Gertz BJ et al.
Clin Pharmacol Ther 1995

Lin JH et al.
Bone 1996

Chesnut CH III et al.
Am J Med 1995

Harris ST et al.
JAMA 1999

Similar Publications